Progressive microvascular complications are a main feature of diabetes and are associated with impairment of the angiogenic response. Methylglyoxal (MGO) has been implicated in the molecular events that lead to endothelial dysfunction in diabetes. In this study, we hypothesize that increased levels of MGO disrupt the ratio of vascular endothelial growth factor (VEGF) to angiopoietin 2 (Ang 2) secreted by retinal pigment epithelial (RPE) cells, which provides a key destabilizing signal that leads to apoptosis and decreased proliferation of retinal endothelial cells. Indeed, we show that MGO increases the levels of Ang 2 and dramatically decreases the levels of VEGF secreted by RPE cells in response to hypoxia. Downregulation of VEGF is likely to be related to decreased hypoxia-inducible factor-1α (HIF-1α) protein levels and HIF-1 transcriptional activity. Data further show that MGO-induced imbalance in the VEGF/Ang II ratio significantly changes the levels of BAX and Bcl-2 in endothelial cells. Moreover, this imbalance is accompanied by an increase in the activity of caspase-3 and decreased proliferation of endothelial cells. Data obtained in cell culture systems are consistent with observations in retinas of diabetic animals, where increased availability of MGO is associated with changes in distribution and levels of HIF-1α, VEGF and Ang 2 and increased microvascular permeability. In conclusion, the MGO-induced imbalance in the VEGF/Ang 2 ratio secreted by retinal epithelial cells activates apoptosis and decreases proliferation of retinal endothelial cells, which are likely to contribute to endothelial dysfunction in diabetic retinopathy.
the impaired angiogenic response (Stitt et al. 2005) . Methylglyoxal is a highly reactive α-oxoaldehyde formed as a byproduct of glycolysis, and its production is enhanced by exposure of cells to high levels of glucose (Kalapos, 1999; Ramasamy et al. 2006) . Methylglyoxal is associated with the formation of acellular capillaries and pericyte dropout in diabetic rats (Hammes, 2003; Hammes et al. 2003) . Moreover, it has been shown that AGEs attenuate the angiogenic response in vitro (Teixeira & Andrade, 1999) , while in diabetic mice in vivo, inhibition of the formation of AGEs can restore ischaemia-induced angiogenesis in peripheral limbs (Tamarat et al. 2003) . Interestingly, MGO increases the expression of angiopoietin 2 (Ang 2; Hammes et al. 2004; Yao et al. 2007) in diabetic retinas, which in the absence of pro-angiogenic factors induces vessel destabilization and regression, as observed in models of solid tumours (Maisonpierre et al. 1997; Holash et al. 1999; Yancopoulos et al. 2000) . The function of Ang 2 appears to be highly dependent on the presence of vascular endothelial growth factor (VEGF; Maisonpierre et al. 1997; Holash et al. 1999; Oshima et al. 2004; Feng et al. 2008) . For example, increased levels of Ang 2 in the presence of low concentrations of VEGF were shown to result in endothelial cell death and vessel regression, whereas in the presence of high levels of VEGF there is increased proliferation and stimulation of angiogenesis.
In this study, we show that exposure of retinal pigment epithelial (RPE) cells to MGO leads to destabilization of hypoxia-inducible factor-1α (HIF-1α), which is a key regulator of VEGF. Consistently, treatment with MGO resulted in decreased transcriptional activity of HIF-1 and decreased levels of VEGF secreted by epithelial cells. Conversely, data also showed that MGO led to an increase in the levels of Ang 2 secreted by these cells. The net result was a dramatic decrease in the ratio between VEGF and Ang 2 secreted into the culture medium. This, in turn, led to a significant decrease in the proliferation of endothelial cells incubated in preconditioned media, as well as increased activity of caspase-3. Data obtained in cell culture systems was consistent with observations in retinas of a diabetic animal model. Altogether, the data suggest that the VEGF/Ang 2 ratio imbalance induced by MGO activates the apoptotic cascade and decreases proliferation of endothelial cells, possibly contributing to vascular dysfunction in situations of increased availability of MGO, such as diabetes.
Methods

Cell culture and treatments
The retinal pigment epithelial cell line ARPE-19 (LGC Promochem, Teddington, UK) was cultured in Ham's F12/Dulbecco's modified Eagle's medium (DMEM; 1:1) supplemented with 10% fetal bovine serum, antibiotics (100 U ml −1 penicillin and 100 μg ml −1 streptomycin) and GlutaMax (1×). This cell line was maintained at 37
• C in an atmosphere of air containing 5% CO 2 . The conditionally immortalized rat retinal endothelial cell line TR-iBRB (Hosoya et al. 2001 ) was a kind gift from Dr K. Hosoya (Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan). The TR-iBRB cells were maintained at 33
• C in an atmosphere of air containing 5% CO 2 in DMEM with low glucose (5.5 mM), supplemented with 10% fetal bovine serum, 100 U ml −1 penicillin and 100 μg ml −1 streptomycin. All media, GlutaMax and non-essential amino acids were purchased from Invitrogen (Carlsbad, CA, USA). When appropriate, cells were treated as indicated with the following agents: methylglyoxal (MGO; Sigma-Aldrich, St Louis, MO, USA), recombinant VEGF 165 and recombinant Ang 2 (R&D Systems, Minneapolis, MN, USA). For the hypoxic treatments (2% O 2 ), a Nuaire N4950E incubator (Nuaire, Plymouth, MN, USA) was used.
Preconditioning protocol
Subconfluent ARPE-19 cells were treated as described above. After the treatments, cell culture media were collected and centrifuged for 10 min at 5000g (to pellet cell debris). Subsequently, MGO that might remain in the media was eliminated by filtration using centricons (with a cut-off of 10 kDa; Millipore, Bedford, MA, USA). For this purpose, the components of the preconditioned media (3 ml total volume) were concentrated to a volume of 100 μl and subsequently resuspended to a final volume of 3 ml of fresh medium. Levels of MGO in the media were assessed by HPLC. Levels of MGO that remained in the media after centrifugation and resuspension were undetectable. The preconditioned media were used to incubate TR-iBRB cells for 24 or 48 h. At the beginning of the incubation, TR-iBRB cells were at 50% (for 24 h of incubation) or 30% of confluence (for 48 h of incubation).
Animal models
Male diabetic Goto-Kakizaki (GK) and control Wistar rats (6 months old) were obtained from local breeding colonies maintained at the animal facility of the Faculty of Medicine, University of Coimbra. The animals were subjected to a constant daily cycle of 12 h light and 12 h dark with constant temperature (22-24
• C) and humidity (50-60%). Rats were given free access to water and to standard commercial pelleted chow diet (AO4; Panlab, Barcelona, Spain). The animals were anaesthetized using ketamine chloride (75 mg kg −1 , I.M., Parke-Davis, Ann Arbor, MI, USA) and chlorpromazine chloride (2.65 mg kg −1 , I.M., LabVitoria, Amadora, Portugal) and were killed by cervical dislocation. The eyes were enucleated and retinas isolated. Retinas were frozen in liquid nitrogen or embedded in OCT tissue embedding matrix (Thermo Scientific, Waltham, MA, USA) at −45
• C for subsequent cryosectioning. Retinas used for HPLC or Western blotting were homogenized with a Potter Elvehjem homogenizer in 300 μl of lysis buffer (50 mM Tris-HCl (pH 7.4), 250 mM NaCl and 1× protease inhibitor cocktail), incubated for 1 h on ice and briefly sonicated. In the case of lysates used for HPLC, protein concentration was determined and normalized. Subsequently, 100 μl of sample (at a concentration of 1 μg μl −1 ) was mixed with 100 μl HCl (0.2 M), and the subsequent procedures were performed as explained in the online Supplemental Methods. In the case of samples used for Western blotting, cell lysates were centrifuged at 16,000g for 10 min at 4
• C, and the supernatants were transferred to new tubes and were used to determine protein concentration. The concentration of all samples was normalized, and samples were denaturated with 2× Laemmli buffer, boiled at 100
• C for 5 min and used for immunoblotting, as explained in the online Supplemental Methods. All experiments involving animals were performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Antibodies and plasmids
The following antibodies were used in this work: mouse anti-HIF-1α clone H1alpha67 (Abcam, Cambridge, UK), mouse anti-actin clone C4 (Millipore-Chemicon, Billerica, MA, USA), mouse anti-Bcl-2 clone C-2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse anti-V5 tag clone 2F11F7 (Invitrogen), rat anti-GLO1 clone 6F10 (Abcam), rabbit anti-VEGF (Ab-4; Calbiochem, San Diego, CA, USA), rabbit anti-Ang 2 (Abcam), rabbit anti-BAX ( 21; Santa Cruz Biotechnology), rabbit anti-Ki67 (SP6; Abcam) and rabbit anti-von Willebrand Factor (vWF; Dako, Glostrup, Denmark). The plasmids pAD/V5-hGLOI and pcDNA6.2-GW/EmGFP-mIR hGLOI were kindly provided by Drs C. Marques (IBILI -Faculty of Medicine, University of Coimbra, Portugal) and J. Ramalho (CEDOC -Faculty of Medical Sciences, New University of Lisbon, Portugal). The pT81 HREluciferase plasmid was kindly provided by Dr S. B. Catrina (Karolinska Institute, Stockholm, Sweden).
Luciferase assay
ARPE-19 cells were plated in 24-well plates at subconfluent density and transfected with pT81 HREluciferase (Catrina et al. 2004 ), using Lipofectamine 2000 . The plasmid pT81/HRE-luciferase contains three tandem copies of the erythropoietin hypoxia responsive element (HRE) in front of the herpes simplex thymidine kinase promoter. Twenty-four hours after transfection cells were treated and assayed for luciferase activity, which was measured using an LMax II 384 ROM v1.04 reader (Molecular Devices, Sunnyvale, CA, USA) according to the manufacturer's protocol. The tested treatments had no effect on the readout of the luciferase reporter assay (assessed by transfection of pCMV luciferase).
Determination of VEGF and Ang 2 levels
The concentrations of diffusible Ang 2 and VEGF 121 , 165 in the cell culture supernatants were measured by Quantikine ELISA kits (R&D Systems), using monoclonal antibodies directed against human Ang 2 or human VEGF. Absorbance was measured at 450 nm, with wavelength correction at 570 nm, on a Biotek Synergy HT spectrophotometer (Biotek, Winooski, VT, USA).
MTT cell viability assay
After the treatments, ARPE-19 cells seeded onto 24-well plates were washed twice with PBS and incubated with 0.5 mg ml −1 MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Invitrogen], solubilized in Krebs buffer (mM: 130 NaCl, 4 KCl, 1.5 MgCl 2 , 1 CaCl 2 , 6 glucose and 10 Hepes, pH 7.4), for 2 h at 37
• C in a cell culture incubator. Subsequently, supernatants were removed, and the precipitated dye was dissolved in 300 μl 0.04 M HCl (in isopropanol) and colorimetrically quantified at 570 nm, with wavelength correction at 620 nm, using a Biotek Synergy HT spectrophotometer.
5-Bromo-2 -deoxyuridine (BrdU) incorporation colorimetric assay
TR-iBRB cells seeded onto a 96-well plate were incubated with BrdU labelling solution to a final concentration of 10 μM for 6 h at 37
• C. Detection of BrdU incorporated on DNA during proliferation was assessed using a specific antibody against BrdU conjugated with peroxidase (anti-BrdU-POD), which develops a photometric signal in the presence of the substrate solution tetramethyl benzidine (TMB), as described by the manufacturer's protocol (Roche Applied Science, Indianapolis, IN, USA). Absorbance was measured at 370 nm on a Biotek Synergy HT spectrophotometer.
Caspase-3 cleavage activity colorimetric assay TR-iBRB cells cultured in 100 mm × 20 mm plates were treated as described in the legend of the figures. Subsequently, cells were lysed, and protein concentration was determined using the BCA method (Pierce-Thermo Scientific, Waltham, MA, USA). The protein lysate was incubated with a specific caspase-3 substrate that is conjugated to the colour reporter molecule Exp Physiol 00.00 pp 1-16 p-nitroanaline (DEVD-pNA) for 2 h at 37
• C, according to the manufacturer's protocol (R&D Systems). The cleavage of the peptide was quantified spectrophotometrically at 405 nm using a Biotek Synergy HT spectrophotometer.
Fibrin gel in vitro angiogenesis assay
TR-iBRB cells resuspended in positive control media or test media were embedded within fibrinogen/thrombin polymerized gels in 96-well plates at a final concentration of 5 × 10 4 cells ml −1 , as described by the manufacturer's protocol (Biotek). Cells were incubated for 24 or 48 h, and phase-contrast images were taken using an inverted light microscope at 100 and ×200 magnification.
Statistical analysis
Data are reported as the means ± S.D. or S.E.M. of at least three independent experiments. Comparisons between multiple groups were performed by one-way ANOVA, while comparison between two groups was performed using an unpaired Student's t test (GraphPad Prism 5.0 software, La Jolla, CA, USA). In all cases, P < 0.05 was considered significant.
Additional details regarding materials and methods are described in the online Supplemental Methods.
Results
Methylglyoxal destabilized HIF-1α and decreased the HIF-1 transcriptional activity in RPE cells
Cell dysfunction in diabetes is related, at least in part, to lack of cellular ability to adapt to low oxygen. For example, Catrina et al. (2004) showed that hyperglycaemia downregulates HIF-1α by a p53-and proline hydroxylation-independent mechanism. Based on previous data, we hypothesize or hypothesized that MGO is likely to be a molecular link between hyperglycaemia and destabilization of HIF-1 in diabetes. Indeed, data in this study showed that MGO downregulated HIF-1α protein levels (Fig. 1A) . Consistently, immunofluorescence data showed that hypoxia led to a remarkable accumulation of HIF-1α in the nucleus, while MGO induced a marked decrease in the levels of HIF-1α present in the nucleus (Fig. S1 ). This MGO-induced decrease in protein levels is likely to account for decreased transcriptional activity of HIF-1. Indeed, through an HRE-driven luciferase reporter assay, we observed that MGO significantly decreased the activation of HIF-1 (Fig. 1B) . This indicates that MGO-induced destabilization of HIF-1α correlates with decreased transcriptional activity of HIF-1. In this study, we used a retinal epithelial cell line (ARPE-19) to investigate the role of MGO in regulation of HIF-1. Retinal pigment epithelial cells are a good model to evaluate the cellular response to hypoxia because these cells are extremely sensitive to variations in oxygen concentration (Yu & Cringle, 2005) and are a major source of proand anti-angiogenic factors in the eye (Slomiany & Rosenzweig, 2004; Strauss, 2005) . Moreover, incubation of ARPE-19 cells with 3 mM MGO for 90 min or 3 h resulted in an intracellular accumulation of MGO of 0.77 ± 0.135 and 0.63 ± 0.113 nmol MGO (mg protein) −1 (versus 0.35 ± 0.074 nmol MGO (mg protein) −1 ; Fig. 1C ). The decrease of MGO after 3 h of incubation probably reflects the scavenging of MGO by glyoxalases (GLOs) and/or irreversible binding of MGO to proteins and other cell components. Moreover, the concentrations and time points used to treat ARPE-19 cells with MGO did not result in significant cell death in comparison with control cultures (P > 0.05, one-way ANOVA; Fig. 1D ). Although the high concentrations used in this work are not found in the plasma and tissues, we observed that they induced an intracellular accumulation of MGO that is consistent with the levels found in tissues of diabetic animals (compare Figs 1C and 5A; Ma et al. 2009 ). Moreover, the obtained intracellular levels of MGO using these concentrations are similar to those observed in other studies using cell culture systems (Miller et al. 2006) . Based on some reports, it is estimated that only a small fraction of exogenous MGO is taken into cells (Che et al. 1997) . Presumably, most of the MGO added to cells reacts with components of the culture medium (e.g. serum), is retained on the cell surface and/or detoxified by the GLO system.
Methylglyoxal increased the levels of Ang 2 and decreased the levels of VEGF secreted by RPE cells
It was recently shown that MGO increases the expression of Ang 2 by a mechanism dependent on the modification of the corepressor mSin3A (Yao et al. 2007) . Moreover, considering prior data, we anticipated that MGO would further decrease the levels of VEGF secreted by cells in hypoxic conditions, since VEGF is a target gene of HIF-1. Indeed, through Western blotting we observed that MGO increased the levels of Ang 2 and decreased the levels of VEGF ( Fig. 2A) , thus leading to a dramatic change in the balance between VEGF and Ang 2. Consistently, MGO increased the levels of Ang 2 and strongly decreased the levels of VEGF secreted into the extracellular space by RPE cells in response to hypoxia (Fig. 2B) .
Data also showed that both GLO I overexpression using an efficient adenovirus-based delivery system ( Fig. 2C ) and GLO I silencing using an miRNA system ( Fig. 2D ) had remarkable effects on the levels of VEGF and Ang 2 secreted into the culture medium. Indeed, GLO I overexpression increased the levels of VEGF secreted by RPE cells in the presence of MGO. Conversely, overexpression of GLO I induced a significant decrease in the levels of Ang 2 secreted by these cells, not only in the presence of MGO, but also in conditions where no MGO was added to the medium (Fig. 2E ). In contrast, silencing of GLO I had similar effects to those observed for the addition of MGO concerning the levels of VEGF and Ang 2 secreted into the medium. Knocking down GLO I decreased the levels of VEGF and increased the levels of Ang 2 secreted by RPE cells (Fig. 2F) . Considering that GLO I is the ratelimiting enzyme involved in detoxification of MGO, this observation provides robust evidence that implicates MGO in changing the VEGF/Ang 2 ratio secreted by these cells. 
. Methylglyoxal decreases the HIF-1α protein levels and decreases HIF-1 transcriptional activity
A, ARPE-19 cells were exposed to hypoxia (2% O 2 ) for 6 h in the absence or in the presence of MGO (3 mM for 10, 60 or 90 min). The cell lysates were analysed by Western blotting (WB) using anti-HIF-1α and anti-actin monoclonal antibodies. B, ARPE-19 cells were transiently transfected with the pT81 HRE-luciferase vector and the cells were subjected to hypoxia (2% O 2 ) for 6 h in the absence or presence of MGO (3 mM for 90 min). Subsequently, the luciferase activity was determined and the values were expressed as multiples of the control value. The results represent the means ± S.D. of at least three independent experiments. * P < 0.05, significantly different from control; #P < 0.05, significantly different from hypoxic conditions (one-way ANOVA with Tukey's multiple comparison test). C, ARPE-19 cells were treated with 3 mM of MGO for 90 min or 3 h. Cells were then lysed, and the intracellular levels of MGO were determined by HPLC after derivatization with 1,2-diamino-4,5-dimethoxybenzene. The results represent the means ± S.D. of at least three independent experiments. * P < 0.05 and * * P < 0.01, significantly different from control values (one-way ANOVA). D, ARPE-19 cells were treated with 3 mM of MGO for 90 min or 3 h and used to assess cell viability through the MTT colorimetric assay. The quantified results represent the means ± S.D. of at least three independent experiments (P > 0.05, one-way ANOVA, Tukey's post hoc test).
Preconditioned medium from epithelial cells treated with MGO activated apoptosis and decreased proliferation of endothelial cells
Imbalance in the VEGF/Ang 2 ratio is likely to induce endothelial dysfunction. We hypothesized that this imbalance induced by MGO in RPE cells would lead to activation of apoptosis and decrease proliferation of endothelial cells. To evaluate this hypothesis, TR-iBRB cells were treated with preconditioned media obtained from ARPE-19 cells subjected to hypoxia in the presence or absence of MGO. TR-iBRB cells exhibit properties of retinal capillary endothelial cells and have been described as an adequate model of inner blood-retinal barrier (Hosoya et al. 2001 ). Considering that ARPE-19 cells are derived from humans (Homo sapiens) and TR-iBRB cells are derived from rats (Rattus norvegicus), the homology of VEGF-A and Ang 2 between both species was investigated before proceeding with additional experiments. As observed in Fig. 3A , the sequences of both VEGF-A and Ang 2 are highly conserved between both species; human VEGF-A (NP 001020537.2) shares 84% of consensus positions with rat VEGF-A (NP 114024.2), while human Ang 2 (NP 001138.1) shares 90.7% of consensus positions with the rat Ang 2 protein (NP 604449.1). Moreover, data published in NCBI databases mention that the VEGF-A binding interface comprises the 230-233, 267, 269-272 and 287-290 residues, while the F468A/Y474A/Y475A and K467E/K472E Ang 2 mutants do not bind Tie2 (Barton et al. 2005) . Vascular endothelial growth factor and Ang 2 sequence alignments show that the mentioned residues (underlined in Fig. 3A ) are fully conserved between both species. Thus, this homology study excludes incompatibility between human VEGF-A and Ang 2 with rat VEGF-R and Tie2 receptors, respectively.
After the homology studies and the validation of our preconditioned cell culture system, the levels of BAX and Bcl-2 in the endothelial cells were determined by immunoblotting. It is well established that the BAX/Bcl-2 ratio determines the response to a death signal (Oltvai et al. 1993) , being a marker of apoptosis activation. Moreover, induction of BAX expression is known to initiate death in the absence of any additional signal (Xiang et al. 1996) , resulting in a downstream programme of mitochondrial dysfunction, as well as activation of caspases. In this study, we observed that the preconditioned medium of ARPE-19 cells subjected to hypoxia strongly increased the Bcl-2 levels in endothelial cells (Fig. 3B) . Conversely, the concentration of diffusible Ang 2 and VEGF-A 121/165 isoforms secreted into the culture medium was determined by ELISA using specific monoclonal antibodies against human VEGF and Ang 2. The results represent the means ± S.D. of at least three independent experiments. * P < 0.05 and * * * P < 0.001, significantly different from control values; #P < 0.05 and ###P < 0.001, significantly different from hypoxia (one-way ANOVA with Tukey's multiple comparison test). C, ARPE-19 cells were infected with pAd V5-GLOI for 48 h. The cell lysates were analysed by immunoblotting using anti-V5 and anti-actin monoclonal antibodies. D, ARPE-19 cells were transfected with pcDNA6.2-GW/EmGFP-miRNA GLO I for 48 h. Cells were subsequently lysed, and protein extracts were immunoblotted for GLO I and actin. E, ARPE-19 cells were infected with pAd V5-GLOI for 48 h. After infection, the cell culture media were replaced by fresh media and cells were subjected to hypoxia for 12 h either in the absence or in the presence of 1 mM MGO. The concentration of diffusible Ang 2 and VEGF-A 121/165 isoforms secreted into the culture medium was determined by ELISA using specific monoclonal antibodies against human VEGF and Ang 2. The results represent the means ± S.D. of at least three independent experiments. * P < 0.05 and * * P < 0.01 (one-way ANOVA with Tukey's multiple comparison test). F, ARPE-19 cells were transfected with pcDNA6.2-GW/EmGFP-miRNA GLO I for 48 h. After transfection, the cell culture media were replaced by fresh media, and cells were subjected to hypoxia for 12 h either in the absence or in the presence of 1 mM MGO. The concentration of diffusible Ang 2 and VEGF-A 121/165 isoforms secreted into the culture medium was determined by ELISA using specific monoclonal antibodies against human VEGF and Ang 2. The results represent the means ± S.D. of at least three independent experiments. * P < 0.05 (one-way ANOVA with Tukey's multiple comparison test). The word 'Mock' in the figures refers to a control with a scrambled miRNA sequence or with an empty vector, depending on the purpose of the experiment. preconditioned medium of ARPE-19 cells simultaneously subjected to hypoxia and MGO decreased the Bcl-2/BAX ratio ( Fig. 3B ) and increased activation of caspase-3 (Fig. 3C) , suggesting activation of apoptosis. We further observed that incubation of endothelial cells with this preconditioned medium decreased the incorporation of BrdU, a synthetic thymidine analogue, in DNA (Fig. 3D) and decreased the levels of the proliferation marker Ki67 (Fig. 3E and F) , indicating decreased proliferation of endothelial cells. The proliferation marker Ki67 is known to be located in the nucleolus during interphase, while it occurs associated with condensed chromosomes during mitosis (Scholzen & Gerdes, 2000) . Indeed, 'MGO' and 'Hypoxia + MGO' conditions were characterized by a small number of cells with a Ki67 mitosis pattern, suggesting decreased cell division/proliferation.
Angiopoietin 2, in the presence of low levels of VEGF, decreased proliferation and activated apoptosis of endothelial cells
Hypoxia and MGO are likely to change the levels of several growth factors and cytokines released by RPE cells, possibly leading to changes in the BAX/Bcl-2 ratio and compromising survival of endothelial cells. To specifically assess the role of VEGF and Ang 2 in the proliferation and survival of endothelial cells, we treated cells with recombinant VEGF and Ang 2 within the same ratios of VEGF/Ang 2 as those that were released by ARPE-19 cells following treatment with MGO and/or hypoxia. We observed that Ang 2, in the presence of high levels of VEGF (conditions that 'mimic' hypoxia), strongly decreased the levels of BAX (Fig. 4A ) in endothelial cells. In contrast, we found that Ang 2, in the presence of for 12 h either in the absence or in the presence of 1 mM MGO. After the elimination of MGO that might remain in the media, preconditioned media were used to incubate TR-iBRB cells for 24 h. The cell lysates were analysed by Western blotting (WB) using specific antibodies against BAX, Bcl-2 and actin. The results represent the means ± S.D. of at least three independent experiments. * * P < 0.01 and * * * P < 0.001, significantly low levels of VEGF (conditions that 'mimic' hypoxia and MGO treatment), induced a strong decrease in the Bcl-2 levels ( Fig. 4A) , dramatically altering the BAX/Bcl-2 ratio and presumably leading to apoptosis. To further confirm this hypothesis, we determined the proteolytic activity of caspase-3, a key executioner of apoptosis (Cohen, 1997; Smulson et al. 1998; Porter & Janicke, 1999) , by using a specific caspase-3 substrate. Data showed that in the presence of low levels of VEGF, Ang 2 significantly increased the caspase-3 activity (Fig. 4B) . Consistently, we also observed that these conditions decreased the incorporation of BrdU in DNA (Fig. 4C ), indicating decreased cell proliferation. In order to further assess the role of the VEGF/Ang 2 ratio in proliferation of retinal endothelial cells, we performed a fibrin gel in vitro angiogenic assay to assess the ability of cultured cells to form tube-like structures. When cultured within a fibrin gel and subjected to angiogenic signals, endothelial cells rapidly align and form interconnecting networks. By using several ratios of VEGF/Ang 2, we observed that Ang 2, in the presence of high levels of VEGF, induced accentuated cell proliferation (Fig. 4D) . Moreover, endothelial cells aligned, forming closed polygons and a network of prototubes. However, Ang 2 in the presence of low levels of VEGF did not favour the formation of proto-tubes or closed polygons, but rather induced isolated growing cells and a few emergent tubes of low complexity (Fig. 4D ).
The retinas of diabetic rats presented increased levels of MGO and changes in the expression and distribution of HIF-1α, VEGF and Ang 2
In this study, we found that MGO destabilized HIF-1α in hypoxic conditions and imbalanced the VEGF/Ang 2 ratio secreted by RPE cells, activating apoptosis and decreasing proliferation of endothelial cells in culture. In order to assess the relevance of these data in a more physiological context, we investigated whether some of the cardinal MGO-induced modifications in cell culture systems were also present in retinas of an animal model of diabetes. For this purpose, we used the GK animal model of diabetes (Goto et al. 1976) , characterized by different from control value; ###P < 0.001, significantly different from hypoxia (one-way ANOVA with Tukey's multiple comparison test). C, TR-iBRB cells, treated with preconditioned media from ARPE-19 cells, were used to determine the caspase-3 cleavage activity by spectrophotometry. The results represent the means ± S.D. of at least three independent experiments. * P < 0.05, significantly different from control values (one-way ANOVA with Tukey's multiple comparison test). D, TR-iBRB cells, treated with preconditioned media from ARPE-19 cells, were incubated with a BrdU labelling solution, and detection of BrdU incorporated into DNA was assessed according to the manufacturers' instructions. The results represent the means ± S.D. of at least three independent experiments. * * * P < 0.001, significantly different from control values; ###P < 0.001, significantly different from hypoxia (oneway ANOVA with Tukey's multiple comparison test). E and F, TR-iBRB cells, incubated as previously described, were used to assess the protein levels (E) and the cellular distribution (F) of the proliferation marker Ki67, by immunoblotting and immunofluorescence, respectively.
increased fasting glycaemia, hyperglycaemia after 2 h of glucose administration and increased levels of glycated haemoglobin (Table S1 ). The GK rat appears to be an appropriate animal model for the study of retinal changes associated with diabetes. Indeed, and as observed for diabetic patients, the GK rats present reduced retinal β-wave amplitudes and reduced oscillatory potentials. These functional abnormalities of the photoreceptors might be associated with inheritable retinal degeneration at an early age (Matsubara et al. 2006) . Abnormalities in microcirculation have also been observed in GK rats at 5 months old, before the appearance of 'clinically' detectable retinal changes (Miyamoto et al. 1996) . Additional features characteristic of diabetic retinal disease include increased apoptosis of retinal microvascular cells and pericytes after 8 months old (Agardh et al. 1997) . Data showed that the retinas of GK rats had increased levels of MGO compared with age-matched control Wistar retinas (Fig. 5A) . We further observed important changes in the expression and distribution of some of the key proteins studied in the cell culture systems. For example, HIF-1α protein was less abundant in the retina of diabetic rats and was mostly expressed in the retinal pigment epithelium and outer plexiform layers (Fig. 5B ) of non-diabetic animals. Consistent with our model, data further showed that VEGF expression was lower in retinas of diabetic compared with non-diabetic rats. Indeed, VEGF was highly expressed in the retinal pigment epithelium and ganglion cell layers (Fig. 5C ) of Wistar animals. Moreover, data also showed that Ang 2 was more abundant in the retina of GK rats (Fig. 5D) . Consistently, we observed by immunoblotting that retinas of diabetic rats presented decreased levels of HIF-1α and VEGF and increased levels of Ang 2 compared with retinas of non-diabetic animals (Fig. 5E ). Taken together, these changes are likely to contribute to a general imbalance between VEGF and Ang 2 across the retina of diabetic animals. Immunohistochemistry data further showed changes in the distribution and expression of BAX and Bcl-2 between retinas of diabetic and non-diabetic animals ( Fig. 5F and G) . For example, GK rats appeared to have low levels of Bcl-2 and high levels of BAX, which may result in an increased amount 165 and Ang 2 for 24 h: I, 6 ng ml −1 VEGF + 4 ng ml −1 Ang 2; II, 20 ng ml −1 VEGF + 4 ng ml −1 Ang 2; and III, 0.5 ng ml −1 VEGF + 7 ng ml −1 Ang 2. Subsequently, the cell lysates were analysed by Western blotting (WB) against BAX, Bcl-2 and actin. The results represent the means ± S.D. of at least three independent experiments. * * P < 0.01 and * * * P < 0.001, significantly different from condition I (one-way ANOVA with Dunnett's multiple comparison test). B and C, TR-iBRB cells, incubated as previously described, were used to determine the caspase-3 cleavage activity by spectrophotometry (B) and the proliferation activity through the BrdU incorporation (C). The results represent the means ± S.D. of at least three independent experiments. * P < 0.05, significantly different from condition I (one-way ANOVA with Tukey's multiple comparison test). D, TR-iBRB cells were embedded within fibrinogen/ thrombin polymerized gels and incubated with recombinant VEGF and Ang 2 proteins. Phasecontrast images were taken using an inverted light microscope 48 h following embedding. The results represent the means ± S.D. of at least three independent experiments, where the number of closed structures were counted per well. * P < 0.05, significantly different from condition I (one-way ANOVA with Tukey's multiple comparison test).
of apoptotic endothelial cells and, consequently, vessel regression, which would translate to less staining for vWF, a specific marker of endothelial cells (Fig. 5H) .
In vivo staining of retinal microvessels with Evans Blue further showed increased vessel permeability in the retinas of GK rats compared with Wistar rats (Fig. 5I) . Evans Blue dye is known to combine with plasma albumin and is a well-accepted tool to monitor vessel leakage. In the early stages of DR, increased capillary leakage is a main feature of blood-retinal barrier breakdown and is a consequence of increased capillary fenestration by disruption of tight junctions between endothelial cells (Harhaj & Antonetti, 2004) .
Altogether, data obtained in animals are consistent with in vitro cell culture data and support a model in which increased levels of MGO decrease the ratio between VEGF and Ang 2 released by active secretory cells, such as RPE cells, leading to apoptosis and decreased proliferation of neighbouring endothelial cells.
Discussion
Hyperglycaemia appears to be a critical factor in the aetiology of diabetes and initiates a number of downstream events, such as pericyte drop-out, vascular obstruction and capillary non-perfusion (Waltenberger, 2001) , which culminate in tissue ischaemia. The cellular response to hypoxia is a fairly complex process that involves activation of HIF-1, a critical step to help cells and tissues to survive and adapt to low oxygen. However, hyperglycaemia was shown to disrupt, at least in part, the ability of tissues to respond and adapt to hypoxia (Abaci et al. 1999; Malmberg et al. 1999; Catrina et al. 2004; Kido et al. 2005) . Although the underlying molecular mechanisms are still unclear, it is conceivable that destabilization of HIF-1α by high glucose concentrations is at the origin of the loss of the cellular response to hypoxia in diabetes (Catrina et al. 2004) . Consistently, downregulation of HIF-1 in response to hyperglycaemia is likely to account for the decreased arteriogenic response triggered by myocardial ischaemia in diabetic patients (Abaci et al. 1999; Larger et al. 2004) . In addition, levels of HIF-1 are downregulated in biopsies from ulcers of diabetic patients compared with venous ulcers that share the same hypoxic environment but are not exposed to hyperglycaemia (Catrina et al. 2004) . These and other lines of evidence strongly suggest that cellular and tissue dysfunction associated with diabetes is related, at least in part, to the lack of cellular ability to adapt and survive in hypoxic conditions. Recent data from our group suggest that increased production of MGO is likely to be a link between hyperglycaemia and destabilization of HIF-1α. Indeed, in the present study we showed that MGO decreased the levels of HIF-1α protein during hypoxia, particularly in the nucleus, and decreased its transcriptional activity. This decrease is likely to account for the downregulation of VEGF, a wellestablished prosurvival and pro-angiogenic factor.
Several lines of evidence suggest that an imbalance in the levels of cytokines might be associated with the vascular complications of diabetes and impaired angiogenic response. Vascularization is regulated by complex context-dependent interactions between, among other factors, Ang 2 and VEGF. Changes in the regulation of either factor are likely to be involved in alterations of the angiogenic remodelling programme. Diabetes induces a significant increase in retinal expression of Ang 2 in rats (Hammes et al. 2004) , and diabetic Ang 2 +/− mice have both decreased pericyte loss and reduced acellular capillary formation compared with diabetic wild-type strain Ang 2 +/+ (Hammes et al. 2002) . Moreover, experimental evidence suggests that decreased levels of VEGF might be associated with wound-healing disorders in diabetic patients (Altavilla et al. 2001) , and simvastatin-induced VEGF expression or topical VEGF application ameliorates impaired wound healing (Galiano et al. 2004; Singh et al. 2007; Bitto et al. 2008) . Furthermore, following an ischaemic insult, VEGF levels in diabetic hearts remain significantly lower than those in non-diabetic hearts (Marfella et al. 2002 (Marfella et al. , 2004 . In addition, myocardial ischaemia-induced VEGF expression is significantly impaired in diabetic patients (Tuo et al. 2008) , and some of these changes can be reversed by decreasing the levels of Ang 2. These and other observations highlight the critical role for the VEGF-Ang 2 balance in the regulation of angiogenesis, in myocardial injury (Tuo et al. 2008) and in other pathophysiological complications associated with diabetes.
Accumulation of MGO has been implicated in the development of many vascular complications of diabetes (Kalapos, 1999) . Significantly, increased retinal levels of MGO in diabetic rats are associated with the formation of acellular capillaries, drop-out of pericytes (Hammes, 2003; Hammes et al. 2003) and deregulation of angiogenesis (Berlanga et al. 2005) , which are major structural lesions of DR. For example, MGO was shown to increase the expression of Ang 2, a key destabilizing factor involved in the initiation of angiogenic remodelling (Yao et al. 2007) . This mechanism was shown to involve MGO-induced modification of mSin3A that results in increased recruitment of O-GlcNAc-transferase, with a consequent increase in modification of Sp3 by O-linked N-acetylglucosamine. This modification of Sp3 causes decreased binding to a glucose-responsive GC box in the Ang 2 promoter, resulting in increased Ang 2 expression (Yao et al. 2007) . Consistently, in this work we showed that MGO increased the levels of Ang 2 produced and secreted by retinal epithelial cells and decreased the levels of VEGF secreted by these cells. The resulting imbalance in the VEGF/Ang 2 ratio led to increased endothelial cell death Exp Physiol 00.00 pp 1-16
Figure 5. Goto-Kakizaki retinas have increased levels of MGO and changes in the expression and distribution of VEGF and Ang 2 compared with Wistar retinas A, Goto-Kakizaki (GK) and Wistar (WS) retinas were lysed and used to determine the levels of MGO by HPLC after derivatization with 1,2-diamino-4,5-dimethoxybenzene. The results represent the means ± S.D. and are and decreased proliferation, which are likely to account for vascular regression and deregulation of the angiogenic response in diabetes. However, one cannot exclude the role of MGO in the deregulation of other angiogenic factors [such as transforming growth factor-β, tumour necrosis factor-α, interleukins and PEDF (pigment epithelium-derived factor)] that might exert critical effects on the proliferation and apoptosis of endothelial cells.
Although the major purpose of this work was not to study the downstream pathways activated by VEGF and Ang 2 leading to survival, proliferation or apoptosis, it is certainly an interesting issue to pursue in the future. Several reports have shown that activation of VEGF receptors by VEGF-A leads to phosphoinositide 3-kinase, protein kinase B and protein kinase C activation, culminating in increased expression of several survival and proliferation factors [e.g. survivin, IAP (inhibitor of apoptosis) and Bcl-2] and decreased expression and/or activity of various apoptotic factors [e.g. BAD (BCL2-associated agonist of cell death), caspases], while inactivation of the Tie2 receptor by Ang 2 leads to activation of nuclear factor-κB and p53 and inactivation of PI3K/AKT, leading to increased apoptotic cell death (Petrova et al. 1999; Eklund & Olsen, 2006) . Thus, an increase in the levels of Ang 2 and a decrease in the levels of VEGF (as induced by MGO) will most probably induce activation of apoptotic pathways, in detriment to inactivation of survival and proliferative pathways, leading to the overall effects reported in this study.
Diabetes has been characterized by an 'angiogenic paradox' , since both pro-and anti-angiogenic conditions coexist in chronic diabetes. In some microvascular tissues, increased expression of growth factors results in neovascularization. This response has a significant role in advanced stages of DR, which seems to be ameliorated by inhibition of angiogenesis. Conversely, decreased expression of pro-angiogenic factors is associated with impairment of new blood vessel formation, leading to poor wound healing, coronary artery and peripheral limb disease, which is ameliorated by induction of release of representative of each group, composed of at least three animals. * P < 0.05, significantly different from control values (Student's unpaired t test). In B, C and D, Goto-Kakizaki and Wistar rat retinas were frozen in OCT tissue embedding matrix and subsequently cryosectioned. Retinal slices 5-7 μm thick were fixed with cold acetone and used to perform immunohistochemistry using specific antibodies against HIF-1α (B), VEGF (C) and Ang 2 (D). Retinas were imaged by fluorescence microscopy, and images are representative of each group of animals. E, Wistar and GK retinal extracts were immunoblotted against HIF-1α, VEGF, Ang 2 and actin. Western blots (WB) are representative of each group, composed of at least three animals. The results represent the means ± S.D.; * P < 0.05, significantly different from Wistar (Student's unpaired t test). F, G and H, Goto-Kakizaki and Wistar retinas were frozen in OCT tissue embedding matrix and subsequently cryosectioned. Retinal slices 5-7 μm thick were fixed with cold acetone and used to perform immunohistochemistry using specific antibodies against BAX (F), Bcl-2 (G) and vWF (H). Retinas were imaged by fluorescence microscopy, and images are representative of each group of animals. I, Goto-Kakizaki and Wistar rats were injected with an Evans Blue (red) solution through the jugular vein 30 min before the animals were killed. Flat-mounted retinas were imaged by fluorescence microscopy, and images are representative of each group of animals. The arrows indicate leakage sites. growth factors. Thus, two apparently opposite angiogenic responses occur in diabetes and generate an intriguing paradox (Duh & Aiello, 1999) .
Several reports suggest that VEGF plays a central role in mediating diabetic vascular complications and is likely to be at the basis of the angiogenic paradox of diabetes. In the case of DR, it is clearly established that VEGF is a major mediator of retinal neovascularization, serving a pivotal role in the aetiology of advanced stages of DR. In fact, VEGF concentrations are markedly elevated in both vitreous and aqueous fluids of patients with active proliferative DR compared with samples from patients without diabetes, with non-proliferative DR or with quiescent proliferative DR (Aiello et al. 1994; Duh & Aiello, 1999) . However, early stages of DR are characterized by opposite phenotypes, mainly associated with formation of acellular capillaries, pericyte drop-out, impairment of the angiogenic response and increased vessel permeability, accounting for blood-retinal barrier breakdown.
Despite all the advances in the understanding of DR, the nature and time course of molecular changes in the diabetic retina are poorly characterized, and studies on expression of VEGF have produced conflicting results. For example, retinal VEGF mRNA levels have been reported by independent studies to be unchanged at 3 months, increased at 6 months and decreased at 6 months following streptozotocin-induced diabetes in rats (Brucklacher et al. 2008) . Moreover, a recent study, based on a gene expression profile, shows a consistent decrease in VEGF mRNA expression in the retina of 1-and 3-month-old streptozotocin-induced diabetic rats (Brucklacher et al. 2008 ). This work also shows that the decrease in the VEGF mRNA levels is accompanied by increased vascular permeability and caspase-3 activity, two main features of the early stages of DR, which are typically associated with increased expression of VEGF. This observation was also corroborated by the present study. Indeed, in this work we showed that increased vessel permeability and apoptosis were accompanied by decreased levels of VEGF in 6-month-old GK diabetic rats. Thus, it seems that there are multiple phases in the regulation of vegf gene expression at different stages of DR, and it seems imprudent to generalize the upregulation of VEGF for all the stages of the disease.
In conclusion, the results reported in this paper are consistent with a number of diverse observations that implicate the VEGF-Ang 2 interplay in the vascular complications observed in diabetes and, in particular, on the propensity to develop DR. In this study, we suggest that high glucose, by increasing the intracellular levels of MGO, is likely to disrupt the VEGF-Ang 2 balance, resulting, at least in part, in characteristic features of the early stages of diabetic vascular complications, such as endothelial cell death, vascular regression and increased microvascular leakage.
